Note 12 - Equity Instruments |
9 Months Ended | ||
|---|---|---|---|
Sep. 30, 2018 | |||
| Notes to Financial Statements | |||
| Stockholders' Equity Note Disclosure [Text Block] |
During September 2018, the Company entered into a Stock Purchase Agreement with an investor, pursuant to which the Company issued to the investor in a private placement (the “Private Placement”) 18,320,610 shares (the “Securities”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $3.0 million (the “Purchase Price”). The Company plans to use the proceeds from the Private Placement for general working capital purposes, including, without limitation, research and development, and other operating expenses.During the nine -month periods ended September 30, 2018 and 2017, we issued 1,118,760 and 710,353 shares of our common stock valued at $317,000 and $369,000, respectively, to our employees as payments in lieu of cash for their 2017, 2016 and 2015 bonuses.During the nine -month periods ended September 30, 2018 and 2017, we issued 94,684 and 105,308 shares of our common stock as matching contributions to our 401 (k) Plan which were valued at $36,000 and $54,000, respectively.During the
nine -month period ended September 30, 2017, we issued 16,406 shares of our common stock valued at $10,500 to certain members of our Board of Directors as payment in lieu of cash for their retainer fees. We did not make any such stock payments to our directors during the nine -month period ended September 30, 2018.
|